Latest news with #GEHealthCare
Yahoo
37 minutes ago
- Business
- Yahoo
GE HealthCare raises annual profit forecast on smaller tariff impact
(Reuters) -GE HealthCare Technologies raised annual profit forecast on Wednesday, as the medical device maker expects a smaller hit from tariffs. The company expects adjusted profit of $4.43 to $4.63 per share for 2025, compared with its previous range of $3.90 to $4.10 per share. The forecast includes a 45-cent-per-share impact from tariffs, which is lower than the 85 cents or $500 million hit it expected in April. Other medical device maker Boston Scientific and healthcare conglomerate Johnson & Johnson, whose costs were exclusively tied to its medtech unit, also halved their expectations for tariff-related costs for the year to about $100 million and $200 million, respectively. GE HealthCare expects annual organic revenue growth of 3%, compared with its previous forecast of a 2% to 3% increase. analyst Robbie Marcus said the company's outlook was "good enough as a more in-line organic growth performance is balanced against conservative tariff assumptions that could/will likely leave upside on the table". GE HealthCare also beat Wall Street estimates for second-quarter profit and revenue, driven by growth in its all four businesses. Revenue at imaging devices, the company's largest segment, grew 2% during the period. Its other units are advanced visualization solutions, patient care solutions and pharmaceutical diagnostics. Medical device manufacturers have been benefiting from still-high demand for elective surgical procedures in the United States, especially among older adults. GE HealthCare's total revenue came in at $5.01 billion during the quarter ended June 30, compared with analysts' average estimate of $4.96 billion, according to data compiled by LSEG. On an adjusted basis, it earned $1.06 per share, compared with the estimate of 92 cents per share. The company said its adjusted core margin was down 80 basis points during the quarter, impacted by tariffs.
Yahoo
4 hours ago
- Business
- Yahoo
GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
Key Takeaways GE HealthCare beat estimates for the second quarter on Wednesday and raised its full-year profit forecast. However, the outlook is still below where it was at the start of the year due to the expected tariff impact. Sales rose across all four of GE HealthCare's segments in the HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year. The former General Electric division said it generated $5 billion in revenue and earned $1.06 per share, each up from the same time a year ago and better than the analyst consensus compiled by Visible Alpha. Sales rose across all four of GE HealthCare's segments in the quarter. The company said it now expects organic revenue growth of about 3% this year, narrowed from its previous range of 2% to 3%. Adjusted earnings per share are now forecast from $4.43 to $4.63, up from $3.90 to $4.10, with the new range including an expected headwind from tariffs of about 45 cents, down from 85 cents previously. While the tariff impact is smaller than what GE HealthCare expected last quarter, the company's adjusted EPS range is still below where it was at the start of the year. GE HealthCare topped estimates last quarter and announced a new stock buyback plan, outweighing the lowered profit forecast. Each of the other two former GE divisions, GE Aerospace (GE) and GE Vernova (GEV), beat estimates in their own second-quarter results earlier this month. Despite the solid results, GE HealthCare shares were down about 2% shortly ahead of markets opening. Read the original article on Investopedia
Reuters
4 hours ago
- Business
- Reuters
GE HealthCare raises annual profit forecast on smaller tariff impact
July 30 (Reuters) - GE HealthCare Technologies (GEHC.O), opens new tab raised annual profit forecast on Wednesday, as the medical device maker expects a smaller hit from tariffs. The company expects adjusted profit of $4.43 to $4.63 per share for 2025, compared with its previous range of $3.90 to $4.10 per share. The forecast includes a 45-cent-per-share impact from tariffs, which is lower than the 85 cents or $500 million hit it expected in April. Other medical device maker Boston Scientific (BSX.N), opens new tab and healthcare conglomerate Johnson & Johnson (JNJ.N), opens new tab, whose costs were exclusively tied to its medtech unit, also halved their expectations for tariff-related costs for the year to about $100 million and $200 million, respectively. GE HealthCare expects annual organic revenue growth of 3%, compared with its previous forecast of a 2% to 3% increase. analyst Robbie Marcus said the company's outlook was "good enough as a more in-line organic growth performance is balanced against conservative tariff assumptions that could/will likely leave upside on the table". GE HealthCare also beat Wall Street estimates for second-quarter profit and revenue, driven by growth in its all four businesses. Revenue at imaging devices, the company's largest segment, grew 2% during the period. Its other units are advanced visualization solutions, patient care solutions and pharmaceutical diagnostics. Medical device manufacturers have been benefiting from still-high demand for elective surgical procedures in the United States, especially among older adults. GE HealthCare's total revenue came in at $5.01 billion during the quarter ended June 30, compared with analysts' average estimate of $4.96 billion, according to data compiled by LSEG. On an adjusted basis, it earned $1.06 per share, compared with the estimate of 92 cents per share. The company said its adjusted core margin was down 80 basis points during the quarter, impacted by tariffs.
Yahoo
6 hours ago
- Business
- Yahoo
GE HealthCare raises annual profit forecast on smaller tariff impact
(Reuters) -GE HealthCare Technologies raised annual profit forecast on Wednesday, as the medical device maker expects a smaller hit from tariffs. The company expects adjusted profit of $4.43 to $4.63 per share for 2025, compared with its previous range of $3.90 to $4.10 per share. The forecast includes a 45-cent-per-share impact from tariffs, which is lower than the 85 cents or $500 million hit it expected in April. Other medical device maker Boston Scientific and healthcare conglomerate Johnson & Johnson, whose costs were exclusively tied to its medtech unit, also halved their expectations for tariff-related costs for the year to about $100 million and $200 million, respectively. GE HealthCare expects annual organic revenue growth of 3%, compared with its previous forecast of a 2% to 3% increase. analyst Robbie Marcus said the company's outlook was "good enough as a more in-line organic growth performance is balanced against conservative tariff assumptions that could/will likely leave upside on the table". GE HealthCare also beat Wall Street estimates for second-quarter profit and revenue, driven by growth in its all four businesses. Revenue at imaging devices, the company's largest segment, grew 2% during the period. Its other units are advanced visualization solutions, patient care solutions and pharmaceutical diagnostics. Medical device manufacturers have been benefiting from still-high demand for elective surgical procedures in the United States, especially among older adults. GE HealthCare's total revenue came in at $5.01 billion during the quarter ended June 30, compared with analysts' average estimate of $4.96 billion, according to data compiled by LSEG. On an adjusted basis, it earned $1.06 per share, compared with the estimate of 92 cents per share. The company said its adjusted core margin was down 80 basis points during the quarter, impacted by tariffs. Sign in to access your portfolio
Wall Street Journal
7 hours ago
- Business
- Wall Street Journal
GE HealthCare Raises 2025 Outlook After Earlier Reduction
GE HealthCare GEHC -0.03%decrease; red down pointing triangle raised its outlook for the year after trimming its forecast earlier in the year, reflecting greater certainty around tariffs. The maker of magnetic-resonance imaging scanners and other health-care machines now expects organic revenue growth of about 3% year over year compared to a previous forecast of growth between 2% and 3%. It also forecast adjusted earnings per-share in the range of $4.43 to $4.63, which includes around 45 cents in impacts from tariffs, and free cash flow of at least $1.4 billion.
